SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
12629246
Source:
http://linkedlifedata.com/resource/pubmed/id/12629246
Search
Subject
(
65
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0024485
,
umls-concept:C0175668
,
umls-concept:C0205329
,
umls-concept:C0244713
,
umls-concept:C1265611
,
umls-concept:C1280500
,
umls-concept:C1441547
,
umls-concept:C2349943
pubmed:issue
5
pubmed:dateCreated
2003-3-11
pubmed:abstractText
Magnetization transfer (MT) MRI can provide in vivo markers reflecting the severity of irreversible, MS-related brain damage occurring within and outside T2-visible lesions.
pubmed:grant
http://linkedlifedata.com/resource/pubmed/grant/491
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0401060
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-beta
,
http://linkedlifedata.com/resource/pubmed/chemical/interferon beta-1b
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1526-632X
pubmed:author
pubmed-author:BarkhofFF
,
pubmed-author:BeckmannKK
,
pubmed-author:ComiGG
,
pubmed-author:FilippiMM
,
pubmed-author:HahnDD
,
pubmed-author:IngleseMM
,
pubmed-author:KapposLL
,
pubmed-author:MillerD HDH
,
pubmed-author:PolmanCC
,
pubmed-author:PozzilliCC
,
pubmed-author:RovarisMM
,
pubmed-author:ThompsonA JAJ
,
pubmed-author:WagnerKK
,
pubmed-author:YousryT ATA
,
pubmed-author:van WaesbergheJ H T MJH
pubmed:issnType
Electronic
pubmed:day
11
pubmed:volume
60
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
853-60
pubmed:dateRevised
2011-11-3
pubmed:meshHeading
pubmed-meshheading:12629246-Adult
,
pubmed-meshheading:12629246-Brain Diseases
,
pubmed-meshheading:12629246-Disease Progression
,
pubmed-meshheading:12629246-Double-Blind Method
,
pubmed-meshheading:12629246-Female
,
pubmed-meshheading:12629246-Humans
,
pubmed-meshheading:12629246-Injections, Subcutaneous
,
pubmed-meshheading:12629246-Interferon-beta
,
pubmed-meshheading:12629246-Magnetic Resonance Imaging
,
pubmed-meshheading:12629246-Male
,
pubmed-meshheading:12629246-Multiple Sclerosis, Chronic Progressive
,
pubmed-meshheading:12629246-Neuropsychological Tests
,
pubmed-meshheading:12629246-Treatment Outcome
pubmed:year
2003
pubmed:articleTitle
The effect of interferon beta-1b on quantities derived from MT MRI in secondary progressive MS.
pubmed:affiliation
Neuroimaging Research Unit, Department of Neuroscience, Scientific Institute and University Ospedale San Raffaele, Milan, Italy.
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Randomized Controlled Trial
,
Controlled Clinical Trial
,
Research Support, Non-U.S. Gov't
,
Multicenter Study